Analyst Update: Chesapeake Energy and Iradimed Corp

Analysts adjusted their ratings and price targets on Potash Corporation of Saskatchewan (USA) (POT), Chesapeake Energy Corporation (CHK), and Iradimed Corp (IRMD)

Apr 4, 2016 at 2:22 PM

Analysts are weighing in on fertilizer producer Potash Corporation of Saskatchewan (USA) (NYSE:POT), oil-and-gas stock Chesapeake Energy Corporation (NYSE:CHK), and medical device maker Iradimed Corp (NASDAQ:IRMD). Here's a quick roundup of today's brokerage notes on POT, CHK, and IRMD.

POT is 4.5% lower at $16.27, after CIBC cut its opinion on the stock to "sector performer" from "sector outperformer," and its price target to $20 from $23. Potash Corporation of Saskatchewan (USA) went from an eight-year low of $14.64 in late January to a year-to-date peak of $19.37 in early March, but has since backpedaled, and is now on pace to breach its 50-day moving average. But while analysts are less than hopeful -- two-thirds rate the equity a "hold" or worse -- option traders have been ramping up their bullish bets in recent weeks. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), POT's 10-day call/put volume ratio of 8.42 sits 2 percentage points from an annual high.

Ladenberg Thalmann raised its price target on CHK to $4 from $3, but the shares are down 3.9% at $3.68, as oil prices fall. After touching a 16-year low of $1.50 in February, Chesapeake Energy Corporation nearly quadrupled in short order, hitting $5.76 in early March. The stock has since cooled off, and is now testing a foothold atop its 80-day moving average. And while option traders appeared to be eyeing another post-Easter pop, analysts aren't so optimistic, giving CHK 17 "hold" or worse ratings, and just one "strong buy."

IRMD is off 16.8% at $16.11, after the company reported that its FDA application for an MRI-compatible IV infusion pump was denied, and received a price-target cut to $25 from $30 at Roth Capital. Iradimed Corp has shed 43% of its value in 2016, and traders have been betting on more downside. Short interest on the stock rose by nearly 18% during the last two reporting periods and now accounts for 22% of IRMD's total available float. At the equity's typical pace of trading, it could take about three weeks to buy back all these bearish positions.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Apple Inc., Edwards Lifesciences Corp, and Facebook Inc and Analyst Downgrades: Smith & Wesson Holding Corp, SolarCity Corp, and BlackBerry Ltd.

Follow @Schaeffers

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.